Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 449 followers
Latest posts
Last updated 1 minute ago
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 18, Status: Authorised
8 minutes ago
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation...
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 4, Status: Authorised
12 minutes ago
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised
22 minutes ago
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Revision: 2, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation...
Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 11, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation...
Plasma master file timetable: 30-day - Period 2026-2028
about 7 hours ago
Plasma master file timetable: 30-day - Period 2026-2028
Plasma master file timetable: 60-day - Period 2026-2028
about 7 hours ago
Plasma master file timetable: 60-day - Period 2026-2028
Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation: 06/03/2009, Revision: 23, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation...
ICH E14/S7B (R1) Q&As: The clinical evaluation of QT/ QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs - Questions and Answers
1 day ago
ICH E14/S7B (R1) Q&As: The clinical evaluation of QT/ QTc interval prolongation...
Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation: 05/09/2013, Revision: 19, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation...
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 10, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation...